Showing results (151-160 of 200) with videos related to
Sort By:
Pageof 20
Arthritis and Rheumatism|June 26, 2008
Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cellsKexing Fan, Jianxin Dai, Hao Wang, et al.Blood|November 2, 2013
Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFPLei Zhao, Qin Tong, Weizhu Qian, et al.Drug Design, Development and Therapy|September 3, 2024
A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx<sup>®</sup> in Healthy Chinese Male SubjectsFeng Yao, Chenguang Wang, Jie Ding, et al.Chinese Medical Journal|August 14, 2012
Therapeutic effect of an injectable sustained-release sinomenine hydrochloride and sodium hyaluronate compound in a rabbit model of osteoarthritisWen-Guang Liu, Pei-Xue Ling, Xiu-Kun Lin, et al.Bioscience Reports|April 3, 2020
Identification of epigenetic factor KAT2B gene variants for possible roles in congenital heart diseasesYong-Sheng Hou, Jing-Zhi Wang, Shuai Shi, et al.Scientific Reports|September 6, 2018
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattleRan Zhang, Chenjun Tang, Huaizu Guo, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2025
Design, synthesis and biological evaluation of novel HIF-1α PROTACs degrader as potent anti-cervical cancer agentsEn-Jie Zhu, Xing-Sheng Bu, Ying Yue, et al.Scientific Reports|January 23, 2021
Effects of a commercially formulated glyphosate solutions at recommended concentrations on honeybee (Apis mellifera L.) behavioursQi-Hua Luo, Jing Gao, Yi Guo, et al.Organic & Biomolecular Chemistry|September 19, 2017
Double 1,4-addition of (thio)salicylamides/thiosalicylic acids with propiolate derivatives: a direct, general synthesis of diverse heterocyclic scaffoldsHui-Hong Wang, Tao Shi, Wei-Wei Gao, et al.Mabs|June 4, 2010
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allograftsJing Li, Bo Zhou, Jianzhong Shentu, et al.Pageof 20